Central Hepatobiliary Tract Tolerance after Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Toxicity Analysis From a Phase 2 Study

Kang H. C.; Kim W. C.; Kim M. S.; Kang K. M.; Kim J. H.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Central Hepatobiliary Tract Tolerance after Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Toxicity Analysis From a Phase 2 Study

【24h】

Central Hepatobiliary Tract Tolerance after Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Toxicity Analysis From a Phase 2 Study

机译：主要门静脉肿瘤血栓形成肝细胞癌肝细胞癌的中央肝胆耐受性：2阶段研究的毒性分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2017年第2suppla期|共2页
作者
Kang H. C.; Kim W. C.; Kim M. S.; Kang K. M.; Kim J. H.;
展开▼
作者单位

Seoul Natl Univ Hosp Dept Radiat Oncol Seoul South Korea;

Inha Univ Coll Med Incheon South Korea;

Korea Inst Radiol &

Med Sci Seoul South Korea;

Gyeongsang Natl Univ Hosp Jinju South Korea;

Keimyung Univ Dongsan Med Ctr Daegu South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. 肿瘤转移抑制基因KiSS-1和基质金属蛋白酶-9在肝细胞癌门静脉癌栓中的表达 [J] . 侯元凯, 王义, 丛文铭, 癌症（英文版） . 2007,第006期
2. Central Hepatobiliary Tract Tolerance after Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Toxicity Analysis From a Phase 2 Study [J] . Kang H. C., Kim W. C., Kim M. S., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：主要门静脉肿瘤血栓形成肝细胞癌肝细胞癌的中央肝胆耐受性：2阶段研究的毒性分析
3. A Preliminary Analysis of Robotic Radiosurgery Stereotactic Body Radiation Therapy With or Without Sorafenib for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis [J] . Que J. Y., Lin L. C., Lin C. H., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：用门静脉肿瘤血栓形成的肝细胞癌术治疗机械放射外科静态体放射治疗的初步分析
4. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis [J] . Takahide Nakazawa, Hisashi Hidaka, Akitaka Shibuya, BMC Gastroenterology . 2014,第1期

机译：索拉非尼与放疗相比在不可切除的肝细胞癌合并主要门静脉肿瘤血栓形成中的总生存期：倾向评分分析
5. CT image feature analysis in distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy(SABR)for lung cancer: a preliminary study [C] . Sarah A. Mattonen, David A. Palma, Cornells J. A. Haasbeek, Conference on biomedical applications in molecular, structural, and functional imaging . 2013

机译：立体定向消融放疗（SABR）后肺癌的CT图像特征分析与放射复发的区别：初步研究
6. Comparison of linear, bi-dimensional and volumetric measurements in evaluating tumor response of Hepatocellular carcinoma lesions in the arterial and portal venous phases on MRI. [D] . Pratt, Michelle Sherman. 2015

机译：在MRI上评估动脉，门静脉期肝细胞癌病变的线性，二维和体积测量结果的比较。
7. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis [O] . Takahide Nakazawa, Hisashi Hidaka, Akitaka Shibuya, 2014

机译：索拉非尼与放疗相比可切除的肝癌合并主要门静脉肿瘤血栓形成的总体生存率：倾向评分分析
8. Comparison of Clinical Efficacy after Stereotactic Ablative Radiation Therapy with Conventionally Fractionated Radiation Therapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis [O] . J. Yang, W.Y. Huang, C. Lo 2018

机译：肝细胞癌肝癌患者常规分级辐射治疗后临床嗜酸术后临床疗效的比较

Central Hepatobiliary Tract Tolerance after Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Toxicity Analysis From a Phase 2 Study

著录项

相似文献

相关主题

期刊订阅